Vanguard Personalized Indexing Management, LLC Halozyme Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 29,629 shares of HALO stock, worth $1.91 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,629
Previous 22,912
29.32%
Holding current value
$1.91 Million
Previous $1.46 Million
5.4%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding HALO
# of Institutions
629Shares Held
127MCall Options Held
408KPut Options Held
384K-
Black Rock Inc. New York, NY17.6MShares$1.14 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$791 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$384 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$224 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$220 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...